4//SEC Filing
AMMON CAROL A 4
Accession 0001209191-04-040469
CIK 0001100962other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 6:57 PM ET
Size
9.4 KB
Accession
0001209191-04-040469
Insider Transaction Report
Form 4
AMMON CAROL A
DirectorChairman and CEO
Transactions
- Sale
Common Stock, par value $.01 per share
2004-08-09$17.46/sh−1,328,877$23,202,192→ 0 total - Exercise/Conversion
Common Stock, par value $.01 per share
2004-08-09$2.42/sh+1,328,877$3,215,882→ 1,328,877 total - Exercise/Conversion
Class C2 Stock Option
2004-08-09−1,328,877→ 145,655 totalExercise: $2.42From: 2004-08-09Exp: 2007-08-26→ Common Stock (1,328,877 underlying)
Footnotes (2)
- [F1]The exercisability of 1,328,877 Class C2 Options was accelerated in connection with an offering of shares that closed on August 9, 2004. The remaining options become exercisable upon the earlier of an Exit Event (as defined in the underlying option plan as filed with the SEC) or January 1, 2006.
- [F2]Common Stock held by Endo Pharma LLC. The exercise of these stock options did not result in the issuance of additional Common Stock by the Issuer.
Documents
Issuer
ENDO PHARMACEUTICALS HOLDINGS INC
CIK 0001100962
Entity typeother
Related Parties
1- filerCIK 0001179353
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 6:57 PM ET
- Size
- 9.4 KB